This inventor holds 3 USPTO granted patents. Top assignee: Bio-Technology General Corporation. Active years: 1992-1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992-1995
Title: Rachel Oren: Innovator in Superoxide Dismutase Research
Introduction
Rachel Oren is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic compositions. With a total of 3 patents, her work focuses on enhancing the efficacy of superoxide dismutase, an important enzyme in reducing oxidative stress.
Latest Patents
Oren's latest patents include innovative approaches to superoxide dismutase analogs. One of her notable inventions is a novel analog of human superoxide dismutase, which comprises the non-acetylated, non-glycosylated form of the enzyme. This analog features a ser-met amino acid sequence attached to the N-terminus. Additionally, she has developed methods for catalyzing chemical reactions using this novel analog and a mixture that includes the natural enzyme. Another significant patent involves an improved plasmid designed for the production of superoxide dismutase or its analogs. This plasmid is engineered to express the gene encoding superoxide dismutase in suitable host cells, enhancing the production of this vital enzyme.
Career Highlights
Rachel Oren is affiliated with Bio-Technology General Corporation, where she continues her research and development efforts. Her work has the potential to catalyze the reduction of superoxide radicals, mitigate reperfusion injury, prolong the survival time of isolated organs, and reduce spinal cord injury. Oren's innovative contributions have positioned her as a key figure in the biotechnology sector.
Collaborations
Some of her notable coworkers include Jacob R. Hartman and Amos B. Oppenheim. Their collaborative efforts have further advanced the research and applications of superoxide dismutase.
Conclusion
Rachel Oren's innovative work in the field of superoxide dismutase research highlights her significant contributions to biotechnology. Her patents and ongoing research continue to pave the way for advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile